| scholarly article | Q13442814 |
| P50 | author | Alain Chapel | Q57090355 |
| P2093 | author name string | Marc Benderitter | |
| Radia Tamarat | |||
| Benoît Usunier | |||
| P2860 | cites work | TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds | Q47842516 |
| Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms | Q47945142 | ||
| Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells | Q48012614 | ||
| Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival | Q48371412 | ||
| Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis | Q24610450 | ||
| Cellular and molecular mechanisms of fibrosis | Q24648892 | ||
| Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats | Q24673267 | ||
| Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium | Q24679838 | ||
| The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 | ||
| Cellular mechanisms of emerging applications of mesenchymal stem cells | Q27024097 | ||
| Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP) | Q28115465 | ||
| A model to predict survival in patients with end-stage liver disease | Q28199900 | ||
| Redox-mediated activation of latent transforming growth factor-beta 1 | Q28294416 | ||
| Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials | Q28484304 | ||
| Potent antioxidant role of pirfenidone in experimental cirrhosis | Q28577533 | ||
| Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-β1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis | Q46664086 | ||
| Renal structural and functional repair in a mouse model of reversal of ureteral obstruction | Q46750147 | ||
| Suitability of 5/6 nephrectomy (5/6NX) for the induction of interstitial renal fibrosis in rats--influence of sex, strain, and surgical procedure | Q46892720 | ||
| Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats | Q46937050 | ||
| Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation | Q46948858 | ||
| New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy | Q46972877 | ||
| Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms | Q47248012 | ||
| Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis | Q47392212 | ||
| Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice. | Q50483913 | ||
| Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. | Q50597496 | ||
| Inhibition of radiation-induced skin fibrosis with imatinib. | Q51302199 | ||
| Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis. | Q51475873 | ||
| Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. | Q51751379 | ||
| Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. | Q51898878 | ||
| Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist. | Q53339381 | ||
| Effects of alpha 1-adrenergic blockade on intrarenal hemodynamics in heart failure rats | Q54276876 | ||
| Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. | Q54473910 | ||
| Immune Modulation by Mesenchymal Stem Cells. | Q55434861 | ||
| Pargyline reduces renal damage associated with ischaemia-reperfusion and cyclosporin | Q57718639 | ||
| Human mesenchymal stem cells express a myofibroblastic phenotype in vitro: comparison to human cardiac myofibroblasts | Q58047134 | ||
| Excess late subcutaneous fibrosis after irradiation of pig skin, consequent upon the application of the NSD formula | Q69767771 | ||
| Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats | Q72018971 | ||
| Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP | Q73042158 | ||
| Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation | Q73804225 | ||
| Acute interstitial pancreatitis in rats induced by dibutyltin dichloride (DBTC): pathogenesis and natural course of lesions | Q73854073 | ||
| Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma | Q77319152 | ||
| Noninvasive evaluation of a novel swine model of renal artery stenosis | Q77998408 | ||
| Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients | Q83414034 | ||
| A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalin | Q83579117 | ||
| Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats | Q83963300 | ||
| Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury | Q85315225 | ||
| Mechanisms of fibrosis: therapeutic translation for fibrotic disease | Q29620307 | ||
| Endothelial-to-mesenchymal transition contributes to cardiac fibrosis | Q29620566 | ||
| Human mesenchymal stem cells modulate B-cell functions | Q29620705 | ||
| Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. | Q31095344 | ||
| Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney | Q33333234 | ||
| Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis | Q33683193 | ||
| Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse | Q33822241 | ||
| Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. | Q33924416 | ||
| Early atherosclerosis aggravates the effect of renal artery stenosis on the swine kidney | Q33995109 | ||
| Renoprotective properties of pirfenidone in subtotally nephrectomized rats | Q34087790 | ||
| Nucleic Acid recognition by metal complexes of bleomycin | Q34105633 | ||
| Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation | Q34116215 | ||
| Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | Q34469147 | ||
| Arterially transplanted mesenchymal stem cells in a mouse reversible unilateral ureteral obstruction model: in vivo bioluminescence imaging and effects on renal fibrosis | Q34722231 | ||
| Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase. | Q34761461 | ||
| HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic | Q34804461 | ||
| Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction | Q35038567 | ||
| Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model | Q35112180 | ||
| Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis. | Q35124912 | ||
| Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model | Q35161538 | ||
| Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects | Q35168236 | ||
| Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. | Q35580538 | ||
| Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases | Q35649473 | ||
| Oral pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study. | Q35840642 | ||
| The biology of the myofibroblast | Q36058077 | ||
| Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis | Q36165804 | ||
| Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats | Q36226666 | ||
| Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window | Q36344710 | ||
| A review of current and novel therapies for idiopathic pulmonary fibrosis | Q36542274 | ||
| Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial | Q36603453 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis | Q36648004 | ||
| Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta | Q36663630 | ||
| Mesenchymal stem cell delivery into rat infarcted myocardium using a porous polysaccharide-based scaffold: a quantitative comparison with endocardial injection | Q36765397 | ||
| Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice | Q36794471 | ||
| Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study | Q36861751 | ||
| Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis | Q36981313 | ||
| Murine models of pulmonary fibrosis. | Q36997546 | ||
| Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling | Q37064631 | ||
| How do mesenchymal stromal cells suppress T cells? | Q37121074 | ||
| Repeated autologous bone marrow-derived mesenchymal stem cell injections improve radiation-induced proctitis in pigs | Q37255064 | ||
| Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. | Q37257183 | ||
| New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy | Q37266540 | ||
| Growth factors and cytokines in wound healing | Q37364066 | ||
| Intestinal fibrosis in IBD--a dynamic, multifactorial process | Q37433780 | ||
| Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell | Q37604825 | ||
| Evaluating pancreatitis in primary care: a population-based cohort study | Q37725828 | ||
| Translation of stem cell therapy for neurological diseases | Q37783805 | ||
| Mesenchymal stem cells: mechanisms of inflammation | Q37809081 | ||
| Strategies for anti-fibrotic therapies | Q38069742 | ||
| Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis | Q38088776 | ||
| Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells. | Q38096939 | ||
| Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. | Q38302488 | ||
| Reduction of fibrosis in dibutyltin dichloride-induced chronic pancreatitis using rat umbilical mesenchymal stem cells from Wharton's jelly | Q39327403 | ||
| Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow | Q39846145 | ||
| The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis | Q39984252 | ||
| Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats | Q40075896 | ||
| Interactions between human mesenchymal stem cells and natural killer cells | Q40385365 | ||
| Schisandra fructus extract ameliorates doxorubicin-induce cytotoxicity in cardiomyocytes: altered gene expression for detoxification enzymes | Q40734989 | ||
| Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model | Q41255321 | ||
| Arterially Delivered Mesenchymal Stem Cells Prevent Obstruction-Induced Renal Fibrosis | Q41418374 | ||
| Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis | Q41690993 | ||
| Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation | Q42095796 | ||
| Effect of mesenchymal stem cells on Doxorubicin-induced fibrosis | Q42217160 | ||
| CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells | Q42437301 | ||
| Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis | Q42513510 | ||
| Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects. | Q42793902 | ||
| Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. | Q43152962 | ||
| Mesenchymal Stem Cells Home to Sites of Injury and Inflammation | Q43198512 | ||
| Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats | Q44288499 | ||
| Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice | Q44981280 | ||
| The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2. | Q45167503 | ||
| Reduction of postischemic immune inflammatory response: an effective strategy for attenuating chronic allograft nephropathy | Q45235006 | ||
| Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis | Q45400930 | ||
| Evaluation of polyelectrolyte complex-based scaffolds for mesenchymal stem cell therapy in cardiac ischemia treatment. | Q45890702 | ||
| Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. | Q46004819 | ||
| Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury | Q46073081 | ||
| Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure | Q46376455 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 340257 | |
| P577 | publication date | 2014-07-14 | |
| P1433 | published in | Stem Cells International | Q26842114 |
| P1476 | title | Management of fibrosis: the mesenchymal stromal cells breakthrough | |
| P478 | volume | 2014 |
| Q33722569 | Amnion Epithelial Cells Promote Lung Repair via Lipoxin A4 |
| Q38838522 | Bowel Radiation Injury: Complexity of the Pathophysiology and Promises of Cell and Tissue Engineering |
| Q36094922 | Cardiac Stem Cell Hybrids Enhance Myocardial Repair. |
| Q38369581 | Cell therapy for liver diseases: current medicine and future promises |
| Q36030447 | Comparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars |
| Q91990726 | Conditioned Medium from Tonsil-Derived Mesenchymal Stem Cells Relieves CCl4-Induced Liver Fibrosis in Mice |
| Q35596843 | Continuing treatment with Salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice |
| Q36353622 | Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis. |
| Q40794119 | Contribution of dermal-derived mesenchymal cells during liver repair in two different experimental models |
| Q38835381 | Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process |
| Q47585861 | Exosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formation. |
| Q64334655 | Fibroblast-myofibroblast crosstalk after exposure to mesenchymal stem cells secretome |
| Q48162963 | Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation. |
| Q60907637 | Heparan Sulfate Mimetics: A New Way to Optimize Therapeutic Effects of Hydrogel-Embedded Mesenchymal Stromal Cells in Colonic Radiation-Induced Damage |
| Q37097724 | Human Amnion-Derived Mesenchymal Stem Cell Transplantation Ameliorates Liver Fibrosis in Rats |
| Q47159235 | Hydrogen sulfide alleviates myocardial fibrosis in mice with alcoholic cardiomyopathy by downregulating autophagy |
| Q92759059 | Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases |
| Q28079649 | Mechanisms of mesenchymal stem/stromal cell function |
| Q37172704 | Melatonin Pretreatment Enhances the Homing of Bone Marrow-derived Mesenchymal Stem Cells Following Transplantation in a Rat Model of Liver Fibrosis. |
| Q64932852 | Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment. |
| Q51761478 | Mesenchymal Stem Cells in the Musculoskeletal System: From Animal Models to Human Tissue Regeneration? |
| Q38395222 | Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives |
| Q55332824 | Mesenchymal Stromal Cell Therapy for Pancreatitis: A Systematic Review. |
| Q26782128 | Mesenchymal stem cell therapy for liver fibrosis |
| Q36928779 | Mesenchymal stem cells are sensitive to bleomycin treatment. |
| Q37144581 | Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder |
| Q47261430 | Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing. |
| Q33722290 | Oncostatin M-Preconditioned Mesenchymal Stem Cells Alleviate Bleomycin-Induced Pulmonary Fibrosis Through Paracrine Effects of the Hepatocyte Growth Factor |
| Q33625006 | Pathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles |
| Q36512529 | Porcine Adipose-Derived Mesenchymal Stem Cells Retain Their Stem Cell Characteristics and Cell Activities While Enhancing the Expression of Liver-Specific Genes after Acute Liver Failure |
| Q48251701 | Protective effects of tannic acid on pressure overload-induced cardiac hypertrophy and underlying mechanisms in rats. |
| Q95314575 | Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients |
| Q38874116 | Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. |
| Q36775830 | Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting |
| Q98564423 | SIRT1-modified human umbilical cord mesenchymal stem cells ameliorate experimental peritoneal fibrosis by inhibiting the TGF-β/Smad3 pathway |
| Q55401793 | Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models. |
| Q42368368 | Surgical Techniques for Managing Post-prostatectomy Erectile Dysfunction |
| Q33842996 | Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction. |
| Q55285430 | Taking advantage of the potential of mesenchymal stromal cells in liver regeneration: Cells and extracellular vesicles as therapeutic strategies. |
| Q58115668 | The mechanisms and potential of stem cell therapy for penile fibrosis |
| Q50455613 | Therapeutic potential of human adipose tissue-derived multi-lineage progenitor cells in liver fibrosis. |
| Q42203768 | Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells. |
| Q28078946 | Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions |
| Q90236333 | Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A |
| Q27003127 | Use of mesenchymal stem cells for therapy of cardiac disease |
Search more.